Optimi Health Corp. (CSE:OPTI)

Market Cap	28.07M +38.6%
Revenue (ttm)	193.60K -62.6%
Net Income	-4.01M
EPS	-0.04
Shares Out	96.78M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	384,225
Average Volume	192,667
Open	0.3050
Previous Close	0.3050
Day's Range	0.2900 - 0.3100
52-Week Range	0.1050 - 0.4200
Beta	1.66
RSI	37.56
Earnings Date	May 15, 2026

About Optimi Health

Optimi Health Corp. operates as a GMP-certified pharmaceutical drug manufacturing company in Canada. The company produces and supplies MDMA, natural psilocybin, psilocin, other psychedelic substances, and functional mushrooms derived from botanical sources for health and wellness markets. The company offers raw mushroom biomass, mushroom extracts, and mushroom supplements, as well as a range of manufacturing of drug products. It sells its products through Amazon marketplace and distributors/brokers, as well as online. Optimi Health Corp. was fo...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2020
• Employees: 8
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: OPTI

Financial Performance

In fiscal year 2025, Optimi Health's revenue was 426,301, an increase of 9.35% compared to the previous year's 389,850. Losses were -3.71 million, -38.50% less than in 2024.